Form D · Hedge Fund

OrbiMed Partners, L.P.

New York, NY · CIK 0000915444

Offering snapshot reported Jul 14, 2017 · SEC filing

Reported sold
$128M
Indefinite offering
Investors reported
130
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 1, 1993
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$64.1M$128MMar 13, 2009Mar 12, 2010: $63,643,125.00Mar 11, 2011: $64,608,125.00Mar 12, 2012: $110,685,733.00Mar 12, 2013: $111,731,000.00Jul 12, 2013: $112,641,000.00Jul 14, 2014: $117,935,033.00Jul 14, 2015: $124,585,033.00Jul 14, 2016: $127,850,033.00Jul 14, 2017: $128,115,033.00Jul 14, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$63,643,125 → $128,115,033
  • Reported investors37 → 130

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 14, 2017Amendment$128,115,033$64,471,908vs Mar 12, 2010130SEC filing
Jul 14, 2016Amendment$127,850,033$64,206,908vs Mar 12, 2010128SEC filing
Jul 14, 2015Amendment$124,585,033$60,941,908vs Mar 12, 2010127SEC filing
Jul 14, 2014Amendment$117,935,033$54,291,908vs Mar 12, 2010121SEC filing
Jul 12, 2013Amendment$112,641,000$48,997,875vs Mar 12, 2010119SEC filing
Mar 12, 2013Amendment$111,731,000$48,087,875vs Mar 12, 2010118SEC filing
Mar 12, 2012Amendment$110,685,733$47,042,608vs Mar 12, 2010117SEC filing
Mar 11, 2011Amendment$64,608,125$965,000vs Mar 12, 201050SEC filing
Mar 12, 2010Amendment$63,643,125No comparison37SEC filing
Mar 13, 2009PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.1
Duration over one year
Yes
Business combination
No
Sales commissions
$3.23M (estimated)
Finders' fees
$0
Form D file number
021-91544-4N
Subject to future contingencies.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Far Hills Group, LLC32243

Source: Form D, filed Jul 14, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sven H. Borho Executive
Carl L. Gordon Executive
Geoffrey C. Hsu Executive
Samuel D. Isaly Executive
W. Carter Neild Executive
Orbi Med Advisors Llc Executive, Promoter
Michael B. Sheffery Executive, Promoter
Jonathan T. Silverstein Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
601 Lexington Avenue, 54 Th Floor
New York, NY, 10022